Thrombectomy Devices Market Analysis & Forecast: 2025-2032

Thrombectomy Devices Market is estimated to be valued at USD 1.95 Bn in 2025 and is expected to reach USD 3.24 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Analysts’ Views on Global Thrombectomy Devices Market:

Thrombectomy devices are used in thrombectomy process. Mechanical thrombectomy devices comprise of a wide array of endovascular tools taht removes thrombi from the neurovasculature in acute ischemic stroke patients. Rising number of patient population with a deep vein thrombosis, pulmonary embolism, and renal vein thrombosis are expected to increase the number of thrombectomy procedures. Thus, it offers the opportunity to various manufacturers to offer various thrombectomy devices such as mechanical thrombectomy and aspiration thrombectomy devices that allows surgeons to perform such surgeries more efficiently.

Figure 1. Global Thrombectomy Devices Market Share (%), By Product Type, 2025

To learn more about this report, Request sample copy

Global Thrombectomy Devices Market– Drivers

• Increasing product approval by regulatory authorities: Increasing product approval by regulatory authorities such as China’s National Medical Product Administration is expected to drive the global thrombectomy devices market growth over the forecast period. For instance, on August 31, 2023, Rapid Medical, a Israel-based developer of neurovascular devices, announced that its Tigertriever revascularization device had received approval from China’s National Medical Product Administration.  Tigertriever provides patient-specific solutions for removing blood clots from the brain in the treatment of ischemic stroke.Moreover, Increasing product approvals by regulatory authority such as U.S. Food and Drug Administration is also expected to boost the global thrombectomy devices market in North America region . For instance, on June 14, 2023, Surmodics Inc., announced that the U.S. Food and Drug Administration had received approval for Pounce LP Thrombectomy System that is  intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature in vessels 3.5 mm to 6 mm in diameter. The Pounce LP Thrombectomy System, a new addition to the Pounce platform, is indicated for use  in vessels, ranging from 2 mm to 4 mm in diameter, sizes typical of vessels found below the knee.

Figure 2. Global Thrombectomy Devices Market Share(%), By Region, 2025

To learn more about this report, Request sample copy

Global Thrombectomy Devices Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global thrombectomy devices market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2025. North America thrombectomy devices market is expected to witness significant growth in the near future due to high prevalence of pulmonary embolism in the region. Increasing prevalence of pulmonary embolism among the patients is expected to drive the North America thrombectomy devices market growth over the forecast period. For instance, according to the data published in The Journal of the American Medical Association, in January 2021, a cross-sectional study was conducted in 7 U.S.-based hospitals among 740 patients  that stated that pulmonary embolism was detected in 5.9% of patients by using a predefined diagnostic algorithm.

Global Thrombectomy Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since, the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of things from one place to another.

However, the COVID-19 pandemic had negative impact on the global thrombectomy devices market as supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries thatled to disruption in the link between warehouses. This shortage of thrombectomy devices and components used in the thrombectomy procedures had affected the supply chain of the global thrombectomy devices market. The COVID-19 pandemic caused major disruptions to clinical trial execution in the U.S., impacting key stakeholders across the medical devices industry. According to the data published by Medrio, global software company, in May 2020, an estimated 80% of non-COVID-19 trials were stopped or interrupted as a result of the COVID-19 pandemic.

Global Thrombectomy Devices Market- Segmentation

Global thrombectomy devices market  is segmented into product type, application, end user, and region.

• Based on product type, the market is segmented into mechanical thrombectomy devices, aspiration thrombectomy devices, hydrodynamic thrombectomy devices, and ultrasonic thrombectomy devices. Out of which, the mechanical thrombectomy devices segment is expected to hold a dominant position in the global thrombectomy devices market during the forecast period due to increasing product launches by key market players.
• Based on application, the market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), superficial vein thrombosis, reneal vein thrombosis (RVT), arterial thrombosis (Atherothrombosis), and Others (Ischemic Stroke, etc.). Out of which, deep vein thrombosis (VBT) segment  is expected to dominate the market over the forecast period due  to increasing prevalence of deep vein thrombosis.
• Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and Others (Academic and Research Institutes, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing number of hospitals for thrombectomy process.
• Among all the segmentation, the application segment is expected to dominate the market over the forecast period due to increasing prevalence of deep vein thrombosis and pulmonary embolism

Global Thrombectomy Devices Market- Cross Sectional Analysis

Among application segment deep vein thrombosis is expected to drive the global thrombectomy devices market over the forecast period due to increasing adoption of inorganic strategies such as launch of campaigns, in order to raise awareness about deep vein thrombosis. For instance, in November 2020, The Bristol Myers Squibb, biopharmaceutical company and Pfizer Inc., pharmaceutical company, Alliance, announced the launch of ‘No Time to Wait’ awareness campaign, to raise awareness about symptoms of deep vein thrombosis. This campaign helps people to find additional information about deep vein thrombosis. 

Global Thrombectomy Devices Market : Key Developments

In April 2022,  Cordis, a medical device company, announced a strategic investment venture with Endovascular Engineering (E2), a developer of next-generation thrombectomy devices, to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). The venture will helps to accelerate the development of thrombectomy devices.

Global Thrombectomy Devices Market: Key Trends

• Increasing acquisition by key market players: Increasing acquisition among key market players. For instance, in September 2021, Boston Scientific Corporation, a global medical device company, announced the acquisition of Devoro Medical, Inc., a developer of the WOLF Thrombectomy Platform. The acquisition included mechanical thrombectomy platform to peripheral interventions portfolio and helps to expand Boston Scientific Corporation thrombectomy devices product portfolio.

Global Thrombectomy Devices Market: Restraint

• Increasing product recall by regulatory authorities: Increasing product recall by regulatory authorities such as U.S. Food and Drug Administration is expected to hinder the market growth over the forecast period. For instance, in February 2022, the U.S. Food and Drug Administration recalled Arrow-Trerotola Percutaneous Thrombolytic Device, manufactured by Arrow-International, LLC a subsidiary of Teleflex Incorporated. The device was recalled due to risk of tip damage during use that canresult in tip detachment from the basket. This could potentially lead to vascular injuries including obstruction (blockage) of the vessel, additional thrombosis (blood clot), ischemia (inadequate blood supply), infarction (heart attack), infection or death.
• Counterbalance: Recall means when a firm removes or corrects a marketed product that the Food and Drug Administration considers to be in violation of the laws, that it administers and against  which the agency would initiate legal action. The customers need to be first informed about the recall procedure and safety of the customers must be ensured at first, so that any damage can be prevented regarding the perception of the brand and the business.

Key players focusing on developing advancing products with safety and cost effective, and this is expected to drive the market growth over the forecast period.

Global Thrombectomy Devices Market - Key Players

Major players operating in the global thrombectomy devices market include include Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.

*Definition: Thrombectomy involves removing a clot from a blood vessel, most commonly from the brain, heart, or lungs. Stroke and myocardial infarction are two of the leading causes of death worldwide, and are increasingly treated through techniques that include intravascular thrombolytics, mechanical thrombectomy, or a combination of both